Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
British Journal of Clinical Pharmacology
|
February 12, 2019
Pharmacokinetics and pharmacodynamics of voxelotor (GBT440) in healthy adults and patients with sickle cell disease
Athiwat Hutchaleelaha, Mira Patel, Carla Washington, et al.
Cancers
|
February 25, 2023
A Contemporary Report of Low-Dose-Rate Brachytherapy for Prostate Cancer Using MRI for Risk Stratification: Disease Outcomes and Patient-Reported Quality of Life
Mira Patel, William Tyler Turchan, Christopher G Morris, et al.
Veterinary Surgery : VS
|
November 3, 2017
Arterial anomalies of the celiac trunk and median arcuate ligament compression in dogs and cats assessed by computed tomography angiography
Hélène M Le Pommellet, Brian A Scansen, Dimitria A Mathys, et al.
Journal of the American Pharmacists Association : Japha
|
March 13, 2017
Patient perceptions of a pharmacy star rating model
Terri L Warholak, Mira Patel, Meagen Rosenthal, et al.
Nanoscale Advances
|
July 24, 2025
Insights into the physicochemical interactions of ionic liquid-coated polymeric nanoparticles with red blood cells
Christine M Hamadani, George R Taylor, Amber Cecil, et al.
ACS Medicinal Chemistry Letters
|
August 20, 2025
Discovery of Osivelotor (GBT021601): A Potent, Next-Generation Sickle Hemoglobin Polymerization Inhibitor
Zhe Li, Carsten Alt, Kobina Dufu, et al.
Blood
|
January 19, 2019
A phase 1/2 ascending dose study and open-label extension study of voxelotor in patients with sickle cell disease
Jo Howard, Claire Jane Hemmaway, Paul Telfer, et al.
Clinical Pharmacology and Therapeutics
|
September 2, 2025
Safety, Pharmacokinetics, and Pharmacodynamics of Osivelotor for Sickle Cell Disease: First-in-Human Studies in Healthy Participants and Patients
Eleanor A Lisbon, R Clark Brown, Andrew Redfern, et al.
JTO Clinical and Research Reports
|
January 26, 2026
Patient-Reported Symptoms and Quality of Life With Sacituzumab Govitecan Versus Docetaxel in Metastatic NSCLC: The Phase 3, Randomized EVOKE-01 Trial
Niels Reinmuth, Sébastien Couraud, Luis Paz-Ares, et al.
British Journal of Haematology
|
March 24, 2023
GBT021601 improves red blood cell health and the pathophysiology of sickle cell disease in a murine model
Kobina Dufu, Carsten Alt, Steven Strutt, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
British Journal of Clinical Pharmacology
|
February 12, 2019
Pharmacokinetics and pharmacodynamics of voxelotor (GBT440) in healthy adults and patients with sickle cell disease
Athiwat Hutchaleelaha, Mira Patel, Carla Washington, et al.
Cancers
|
February 25, 2023
A Contemporary Report of Low-Dose-Rate Brachytherapy for Prostate Cancer Using MRI for Risk Stratification: Disease Outcomes and Patient-Reported Quality of Life
Mira Patel, William Tyler Turchan, Christopher G Morris, et al.
Veterinary Surgery : VS
|
November 3, 2017
Arterial anomalies of the celiac trunk and median arcuate ligament compression in dogs and cats assessed by computed tomography angiography
Hélène M Le Pommellet, Brian A Scansen, Dimitria A Mathys, et al.
Journal of the American Pharmacists Association : Japha
|
March 13, 2017
Patient perceptions of a pharmacy star rating model
Terri L Warholak, Mira Patel, Meagen Rosenthal, et al.
Nanoscale Advances
|
July 24, 2025
Insights into the physicochemical interactions of ionic liquid-coated polymeric nanoparticles with red blood cells
Christine M Hamadani, George R Taylor, Amber Cecil, et al.
ACS Medicinal Chemistry Letters
|
August 20, 2025
Discovery of Osivelotor (GBT021601): A Potent, Next-Generation Sickle Hemoglobin Polymerization Inhibitor
Zhe Li, Carsten Alt, Kobina Dufu, et al.
Blood
|
January 19, 2019
A phase 1/2 ascending dose study and open-label extension study of voxelotor in patients with sickle cell disease
Jo Howard, Claire Jane Hemmaway, Paul Telfer, et al.
Clinical Pharmacology and Therapeutics
|
September 2, 2025
Safety, Pharmacokinetics, and Pharmacodynamics of Osivelotor for Sickle Cell Disease: First-in-Human Studies in Healthy Participants and Patients
Eleanor A Lisbon, R Clark Brown, Andrew Redfern, et al.
JTO Clinical and Research Reports
|
January 26, 2026
Patient-Reported Symptoms and Quality of Life With Sacituzumab Govitecan Versus Docetaxel in Metastatic NSCLC: The Phase 3, Randomized EVOKE-01 Trial
Niels Reinmuth, Sébastien Couraud, Luis Paz-Ares, et al.
British Journal of Haematology
|
March 24, 2023
GBT021601 improves red blood cell health and the pathophysiology of sickle cell disease in a murine model
Kobina Dufu, Carsten Alt, Steven Strutt, et al.
Page
of 4